Cannabis studies lacking

September 13, 2017

ALTHOUGH cannabis contains more than 60 pharmacologically active cannabinoids, the usual pharmacokinetic pharmacodynamic bioavailability and toxicology studies are lacking, the Therapeutic Goods Administration (TGA) says.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 13 Sep 17To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Sep 17

Other recent headlines

CONSUMERS and health professionals are advised that Biogen Australia, in consultation with the Therapeutic Goods Administration (TGA), will withdraw multiple sclerosis therapy Zinbryta (daclizumab) from the Australian market following a review of cases of serious inflammatory brain disorders in Europe (PD 05 Mar).

Pharmacy Daily is Australia's favourite online publication dedicated to the pharmacy industry. The publication launched in March 2007 and is distributed every day by email to pharmacists across the country.